Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

455
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
455
Disorders of Hemostasis01:24

Disorders of Hemostasis

918
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
918
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

187
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
187
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

ISMB 2026 Proceedings.

Bioinformatics (Oxford, England)·2026
Same author

Immune aging biomarkers for clinical trials.

Nature medicine·2026
Same author

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder.

Nature communications·2026
Same author

Dual regulation of metabolic reprogramming and protein competitive modifications: the core role and mechanism of MRPL36 in glioblastoma malignant progression.

Journal of experimental & clinical cancer research : CR·2026
Same author

A Novel Single-Branched Stent-graft System for Aortic Dissection Involving the Aortic Arch.

The Annals of thoracic surgery·2026
Same author

Mutation-dependent responses to sleep and exercise in clonal haematopoiesis.

Nature·2026

関連する実験動画

Updated: Jul 5, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

775

活動中のロング・コービッドにおける血栓炎症の徴候を有する持続的な補完体調節障害

Carlo Cervia-Hasler1, Sarah C Brüningk2,3, Tobias Hoch1

  • 1Department of Immunology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.

Science (New York, N.Y.)
|January 18, 2024
PubMed
まとめ

ロング・コービッドは免疫系,特に補完体系に 異常が生じます この研究では,コンプリメンタと血栓炎症性タンパク質をロング・コービッドの診断と治療の重要なバイオマーカーとして特定しました.

さらに関連する動画

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.3K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.7K

関連する実験動画

Last Updated: Jul 5, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

775
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.3K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.7K

科学分野:

  • 免疫学
  • プロテオミクス
  • 感染症

背景:

  • ロング・コービッドは複雑で 原因が不明で 衰弱する状態です
  • 効果的な治療法の開発には 基礎となる生物学的メカニズムを理解することが重要です

研究 の 目的:

  • マルチモダルプロテオミクスを使って ロング・コビッドの分子メカニズムを調査する
  • ロング・コービッドの診断と治療目標の潜在的バイオマーカーを特定する.

主な方法:

  • 感染後12ヶ月までの268人のCOVID-19患者の血清の長期タンパク質解析.
  • ロング・コービッドと回復した人の違いを特定するために,6500以上のタンパク質を分析した.
  • トップのタンパク質バイオマーカーを特定するために機械学習が適用されます.

主要な成果:

  • ロング・コビッドは,終末型,代替型,古典型経路を含むコンプリメンタル・システムの制御不能な活性化によって特徴付けられます.
  • 血解のマーカー増加,組織損傷,血小板活性化,単細胞血小板集積が観察されました.
  • ヘルペスウイルスに対する抗体位は,古典的な補足経路の活性化と相関する.

結論:

  • 補完体系と血栓炎症はロング・コビッドの病原性にとって中心的なものです.
  • コンプリメントおよび血栓炎症性タンパク質はロング・コビッドの診断および治療用バイオマーカーとして有望である.